USP17L2 and non-small cell lung carcinoma: USP17 depletion was found to enhance the activation of EGFR, Akt and ERK1/2 in NSCLC cells expressing both EGFR DelE746-A750 (Fig. 4A) and EGFR L858R/T790 M (Fig. 4B).